Treatment of Benign Liver Tumor in Focal Nodular Hyperplasia

Clinical Scenario

This protocol addresses the management of benign liver tumor in the context of focal nodular hyperplasia (FNH) — the second most frequent benign tumour of the liver.

Condition Details

Focal nodular hyperplasia is a well-characterised benign hepatic lesion. FNH accounts for the second most frequent benign tumour of the liver and is typically encountered incidentally.

Approach (Summary)

Given the rarity of complications, the recommended approach centres on conservative management rather than active intervention — particularly in asymptomatic presentations.

Full regimen details, criteria, and clinical decision steps are in the complete protocol →

Instant Access to Structured Evidence-Based Regimens

References

FNH accounts for the second most frequent benign tumour of the liver.

In the absence of symptoms and given the rarity of complications, a conservative approach is recommended.

Treatment is not recommended (evidence level II-3, grade of recommendation 2)

DOI: 10.1016/j.jhep.2016.04.001

View source ↗